Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006
Influenza A virus in exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001
Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006
Hospitalization for influenza among patients with chronic obstructive pulmonary disease Source: International Congress 2019 – Airway infection in COPD Year: 2019
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Pneumococcal vaccination coverage in Spanish patients with chronic obstructive pulmonary disease (COPD). Result of the EPIDEPOC study Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004
Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations Source: Annual Congress 2009 - Exacerbations of COPD: new findings Year: 2009
Rate of flu vaccination in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004
Genomic variability of haemophilus in patients with COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
Does influenza vaccination increase consultations for corticosteroid prescriptions or exacerbations of asthma or chronic obstructive pulmonary disease? Source: Annual Congress 2003 - COPD: risk factors and course of disease Year: 2003
Should chronic obstructive pulmonary disease patients must be vaccinated? Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005
Prevalence of chronic obstructive pulmonary disease (COPD) in Greece Source: Eur Respir J 2002; 20: Suppl. 38, 122s Year: 2002
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Predictors of influenza PCR positivity in acute exacerbations of chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020
Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005
Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013